A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/22/2009	CA2479674C New therapeutic use of 5-aminoimidazole-4-carboxamide riboside (acadesine)
12/22/2009	CA2474460C Pyridine- and quinoline-derivatives
12/22/2009	CA2470639C Preparation for wound healing and prevention of bandage adhesion to the wound
12/22/2009	CA2464336C A process for the preparation of the 14beta-hydroxy-baccatin iii-1,14-carbonate
12/22/2009	CA2462369C Compositions for delivery of drug combinations
12/22/2009	CA2461248C Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
12/22/2009	CA2454799C Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
12/22/2009	CA2452558C A synergistic pharmaceutical combination for the prevention or treatment of diabetes
12/22/2009	CA2451106C Sequential drug delivery systems
12/22/2009	CA2447166C Delivery of erectile dysfunction drugs through an inhalation route
12/22/2009	CA2446990C Delivery of sedative-hypnotics through an inhalation route
12/22/2009	CA2446917C Delivery of antipsychotics through an inhalation route
12/22/2009	CA2446916C Delivery of opioids through an inhalation route
12/22/2009	CA2444719C Method of production of an isomaltulose-containing enteral nutrient
12/22/2009	CA2435921C Method of cancer therapy
12/22/2009	CA2434813C Imidazole derivatives
12/22/2009	CA2427301C Method for the preparation of a pharmaceutical composition, and its use
12/22/2009	CA2426210C Treatment of pcp addiction and pcp addiction-related behavior
12/22/2009	CA2418538C Antibacterial mutilins
12/22/2009	CA2418059C Method of treating neurodegenerative disorders of the retina and optic nerve head
12/22/2009	CA2417282C Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid
12/22/2009	CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/22/2009	CA2415214C Phosphotetrahydropyran compounds
12/22/2009	CA2414514C Carbamates derived from arylalkylamines
12/22/2009	CA2413026C Cold water soluble .beta.-glucan product and process for preparing the same
12/22/2009	CA2411568C Compositions for the therapy of dementias
12/22/2009	CA2407559C Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine
12/22/2009	CA2406536C Preparation of injectable suspensions having improved injectability
12/22/2009	CA2406081C Administration of a thiol-based chemoprotectant compound
12/22/2009	CA2405593C Macrolides
12/22/2009	CA2402421C Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals
12/22/2009	CA2395987C Improved pharmaceutical formulations
12/22/2009	CA2391008C Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds
12/22/2009	CA2387973C Pharmaceutical formulation containing tolterodine and its use
12/22/2009	CA2385860C Composition comprising casein protein and whey protein
12/22/2009	CA2373909C Multilayer drug form release in the colon
12/22/2009	CA2371712C Cyclothiocarbamate derivatives as progesterone receptor modulators
12/22/2009	CA2369587C Solubilized pharmaceutical composition for parenteral administration
12/22/2009	CA2368108C Thienopyrimidine compounds, their production and use
12/22/2009	CA2362381C Amide compounds and medicinal use thereof
12/22/2009	CA2348395C Compositions comprising a mixture of bioflavonols
12/22/2009	CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
12/22/2009	CA2346847C Novel imidazoles with anti-inflammatory activity
12/22/2009	CA2346563C Novel 2-[3-phenyl-2-propenyl]-1,2,3,4-tetrahydroxyisoquinoline derivatives, preparation method and use as fungicides
12/22/2009	CA2345297C Synthetic analogs of ecteinascidin-743
12/22/2009	CA2345231C Pharmaceutical compositions comprising derivatives of sulphur acids
12/22/2009	CA2344372C Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
12/22/2009	CA2343325C Topical dermal antimicrobial compositions
12/22/2009	CA2339192C Treatment of addiction and addiction-related behavior
12/22/2009	CA2337571C Antihistamine leukotriene combinations
12/22/2009	CA2330976C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents
12/22/2009	CA2327465C Bipolar lipids capable of delivering polyanions to cells
12/22/2009	CA2326529C 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide
12/22/2009	CA2322327C Treatment of viral disease in swine
12/22/2009	CA2307879C Treatment of t-helper cell type 2 mediated immune diseases
12/22/2009	CA2305803C Crystalline antifungal polymorph
12/22/2009	CA2303973C Prolonged release formulation of carbamazepine
12/22/2009	CA2290744C Cyclic diamine compounds and medicine containing the same
12/22/2009	CA2217032C Fast acting and persistent topical antiseptic
12/22/2009	CA2173839C Transferrin compositions to alleviate the side effects of cytotoxic drugs
12/22/2009	CA2114221C 1, 3-oxathiolane nucleoside analogues
12/20/2009	WO2009156041A2 Thiazolyl piperdine derivatives
12/20/2009	CA2637538A1 Dar 1 (dermal acne remover)
12/19/2009	CA2661953A1 Method, composition, and device, for the treatment of diseases, enzymes and saccharides disorders
12/19/2009	CA2633246A1 Identification of therapeutic agents for hiv infection
12/17/2009	WO2009152500A2 Methods and compositions for mediating gene silencing
12/17/2009	WO2009152462A2 Method of regulating cell growth using a proteasome inhibitor
12/17/2009	WO2009152458A1 Liquid formulation suitable for infusion comprising an adenosine receptor antagonist for treating heart failure and renal insufficiency.
12/17/2009	WO2009152453A2 Compositions and methods for treating pulmonary hypertension
12/17/2009	WO2009152431A1 P2y1 receptor antagonists
12/17/2009	WO2009152430A2 Methods of treatment of bipolar disorder
12/17/2009	WO2009152421A1 Crystalline polymorphs of gemcitabine base
12/17/2009	WO2009152415A2 Reducing myocardial reperfusion injury by the combination therapy of protein kinase a activation and b1-adrenergic receptor blockade
12/17/2009	WO2009152407A1 Therapeutic imprinting for the treatment of psychiatric disorders
12/17/2009	WO2009152392A2 Muscarinic agonists for neurological disorders and methods of making the same
12/17/2009	WO2009152374A2 Method for treating chronic wounds
12/17/2009	WO2009152372A1 Control of blood vessel physiology to treat skin disorders
12/17/2009	WO2009152369A1 Pharmaceutical formulation of ketorolac for intranasal administration
12/17/2009	WO2009152347A2 Crystalline forms of zotepine hydrochloride
12/17/2009	WO2009152344A2 Combination therapy using phosphodiesterase inhibitors
12/17/2009	WO2009152340A2 2,3-substituted thiophenes in lung inflammation therapies
12/17/2009	WO2009152300A1 Use of mir-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
12/17/2009	WO2009152288A1 Substituted benzimidazoles for neurofibromatosis
12/17/2009	WO2009152245A1 Treatment of cancers of the blood using selected glycomimetic compounds
12/17/2009	WO2009152228A2 Use of the combination of phy906 and a tyrosine kinase inhibitor as a cancer treatment regimen
12/17/2009	WO2009152210A2 Coumarin compounds and their use for treating cancer
12/17/2009	WO2009152200A1 Tricyclic indole derivatives and methods of use thereof
12/17/2009	WO2009152192A1 Combination of a triptan and an nsaid
12/17/2009	WO2009152190A1 Escalating dosing regimen for effecting weight loss and treating obesity
12/17/2009	WO2009152189A1 Low dose topiramate/phentermine compostion and methods of use thereof
12/17/2009	WO2009152171A1 Corticosteroid linked beta-agonist compounds for use in therapy
12/17/2009	WO2009152168A2 Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
12/17/2009	WO2009152167A2 Delivery of therapeutics
12/17/2009	WO2009152166A1 [1,2,4]thiadiazine 1,1-dioxide compounds
12/17/2009	WO2009152164A2 Smoking cessation kit and method
12/17/2009	WO2009152160A1 Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension
12/17/2009	WO2009152142A1 Sulfonate salts of flupirtine
12/17/2009	WO2009152095A2 Nucleoside cyclicphosphates
12/17/2009	WO2009152087A1 Bicyclic heteroaryl compounds and methods for kinase modulation, and indications therefor
12/17/2009	WO2009152083A1 5h-pyrr0l0 [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor

1 ... 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 ... 7860